235 related articles for article (PubMed ID: 35460558)
21. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
22. Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation.
Velasco A; Palomar-Asenjo V; Gañan L; Catasus L; Llecha N; Panizo A; Palomar-Garcia V; Quer M; Matias-Guiu X
Diagn Mol Pathol; 2005 Jun; 14(2):109-14. PubMed ID: 15905695
[TBL] [Abstract][Full Text] [Related]
23. Loss of maternal chromosome 11 is a signature event in SDHAF2, SDHD, and VHL-related paragangliomas, but less significant in SDHB-related paragangliomas.
Hoekstra AS; Hensen EF; Jordanova ES; Korpershoek E; van der Horst-Schrivers AN; Cornelisse C; Corssmit EP; Hes FJ; Jansen JC; Kunst HP; Timmers HJ; Bateman A; Eccles D; Bovée JV; Devilee P; Bayley JP
Oncotarget; 2017 Feb; 8(9):14525-14536. PubMed ID: 28099933
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
[TBL] [Abstract][Full Text] [Related]
25. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
Bayley JP; Kunst HP; Cascon A; Sampietro ML; Gaal J; Korpershoek E; Hinojar-Gutierrez A; Timmers HJ; Hoefsloot LH; Hermsen MA; Suárez C; Hussain AK; Vriends AH; Hes FJ; Jansen JC; Tops CM; Corssmit EP; de Knijff P; Lenders JW; Cremers CW; Devilee P; Dinjens WN; de Krijger RR; Robledo M
Lancet Oncol; 2010 Apr; 11(4):366-72. PubMed ID: 20071235
[TBL] [Abstract][Full Text] [Related]
26. W43X SDHD mutation in sporadic head and neck paraganglioma.
Galera-Ruiz H; Gonzalez-Campora R; Rey-Barrera M; Rollón-Mayordomo A; Garcia-Escudero A; Fernández-Santos JM; DeMiguel M; Galera-Davidson H
Anal Quant Cytol Histol; 2008 Apr; 30(2):119-23. PubMed ID: 18561749
[TBL] [Abstract][Full Text] [Related]
27. Predominant expression of mutated allele of the succunate dehydrogenase D (SDHD) gene in the SDHD-related paragangliomas.
Yamashita R; Usui T; Hashimoto S; Suzuki H; Takahashi M; Honkura K; Iwamoto K; Kodama E; Tagami T; Naruse M; Shimatsu A; Kaise K
Endocr J; 2009; 56(9):1129-35. PubMed ID: 19550080
[TBL] [Abstract][Full Text] [Related]
28. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
29. High incidence of occult familial
Guha A; Vicha A; Zelinka T; Kana M; Musil Z; Pacak K; Betka J; Chovanec M; Plzak J; Boucek J
Front Endocrinol (Lausanne); 2023; 14():1278175. PubMed ID: 38144572
[TBL] [Abstract][Full Text] [Related]
30. Mutation Frequency in Main Susceptibility Genes Among Patients With Head and Neck Paragangliomas.
Snezhkina AV; Fedorova MS; Pavlov VS; Kalinin DV; Golovyuk AL; Pudova EA; Guvatova ZG; Melnikova NV; Dmitriev AA; Razmakhaev GS; Poloznikov AA; Alekseeva GS; Kaprin AD; Krasnov GS; Kudryavtseva AV
Front Genet; 2020; 11():614908. PubMed ID: 33391357
[TBL] [Abstract][Full Text] [Related]
31. Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD.
Chatzikyriakou P; Touska P; Moonim MT; Obholzer R; Afridi S; Sandison A; Oakey RJ; Izatt L
Cancer Genet; 2021 Aug; 256-257():110-114. PubMed ID: 34107390
[TBL] [Abstract][Full Text] [Related]
32. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathway.
Merlo A; de Quirós SB; de Santa-María IS; Pitiot AS; Balbín M; Astudillo A; Scola B; Arístegui M; Quer M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1661-6. PubMed ID: 23902947
[TBL] [Abstract][Full Text] [Related]
33. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
[TBL] [Abstract][Full Text] [Related]
34. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene.
Taschner PE; Jansen JC; Baysal BE; Bosch A; Rosenberg EH; Bröcker-Vriends AH; van Der Mey AG; van Ommen GJ; Cornelisse CJ; Devilee P
Genes Chromosomes Cancer; 2001 Jul; 31(3):274-81. PubMed ID: 11391798
[TBL] [Abstract][Full Text] [Related]
35. SDHx gene detection and clinical Phenotypic analysis of multiple paraganglioma in the head and neck.
Ding Y; Feng Y; Wells M; Huang Z; Chen X
Laryngoscope; 2019 Feb; 129(2):E67-E71. PubMed ID: 30484866
[TBL] [Abstract][Full Text] [Related]
36. Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma.
Korpershoek E; Petri BJ; van Nederveen FH; Dinjens WN; Verhofstad AA; de Herder WW; Schmid S; Perren A; Komminoth P; de Krijger RR
Endocr Relat Cancer; 2007 Jun; 14(2):453-62. PubMed ID: 17639058
[TBL] [Abstract][Full Text] [Related]
37. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
[TBL] [Abstract][Full Text] [Related]
38. Relevance of germline mutation screening in both familial and sporadic head and neck paraganglioma for early diagnosis and clinical management.
Hermsen MA; Sevilla MA; Llorente JL; Weiss MM; Grimbergen A; Allonca E; Garcia-Inclán C; Balbín M; Suárez C
Cell Oncol; 2010 Jan; 32(4):275-83. PubMed ID: 20208144
[TBL] [Abstract][Full Text] [Related]
39. The phenotype of
Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
[TBL] [Abstract][Full Text] [Related]
40. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
